In:
Molecular Oncology, Wiley, Vol. 8, No. 3 ( 2014-05), p. 669-678
Abstract:
Improved neuroblastoma risk classification is needed to refine treatment. Microarray signatures provide prognostic information for neuroblastoma patients. Complex technology has limited clinical integration of microarray signatures. Expression signatures can be obtained using nCounter™ system's simple technology.
Type of Medium:
Online Resource
ISSN:
1574-7891
,
1878-0261
DOI:
10.1016/j.molonc.2014.01.010
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
2322586-5